Brunet A, Sweeney LB, Sturgill JF, et al. 2004 Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 2011–2015

Article  CAS  PubMed  Google Scholar 

Chen KJ, Li Q, Wen CM, et al. 2016 Bleomycin (BLM) induces epithelial-to-mesenchymal transition in cultured A549 cells via the TGF-β/smad signaling pathway. J. Cancer 7 1557–1564

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu H, Jiang S, Liu Q, et al. 2018 Sirtuin1 protects against systemic sclerosis–related pulmonary fibrosis by decreasing proinflammatory and profibrotic processes. Am. J. Respir. Cell Mol. Biol. 58 28–39

Article  CAS  PubMed  PubMed Central  Google Scholar 

Contreras-Salinas H, Meza-Rios A, García-Bañuelos J, et al. 2020 Fibrosis regression is induced by AdhMMP8 in a murine model of chronic kidney injury. PLoS One 15 e0243307

Coward WR, Watts K, Feghali-Bostwick CA, et al. 2010 Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol. Cell. Biol. 30 2874–2886

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curry AM, White DS, Donu D, et al. 2021 Human sirtuin regulators: the “success” stories. Front. Physiol. 12 752117

Gálvez-Gastélum FJ, Garcia-Bañuelos JJ, Beas-Zárate C, et al. 2011 Combinatorial gene therapy induces regression of hepatic encephalopathy. Gene Ther. 18 88–94

Article  PubMed  Google Scholar 

García-Bañuelos J, Oceguera-Contreras E, Sandoval-Rodríguez A, et al. 2023 AdhMMP8 vector administration in muscle: an alternate strategy to regress hepatic fibrosis. Cells 12 2127

Garcia-Peterson LM and Li X 2021 Trending topics of SIRT1 in tumorigenicity. Biochim. Biophys. Acta 1865 129952

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gertz M, Fischer F, Nguyen GT, et al. 2013 Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism. Proc. Natl. Acad. Sci. USA 110 E2772–E2781

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guan R, Cai Z, Wang J, et al. 2019 Hydrogen sulfide attenuates mitochondrial dysfunction-induced cellular senescence and apoptosis in alveolar epithelial cells by upregulating sirtuin 1. Aging 11 11844–11864

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henderson NC, Rieder F and Wynn TA 2020 Fibrosis: from mechanisms to medicines. Nature 587 555–566

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Z, Zhang Z, Zhou C, et al. 2022 Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. MedComm 3 e144

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huo R, Huang X, Yang Y, et al. 2023 Potential of resveratrol in the treatment of interstitial lung disease. Front. Pharmacol. 14 1139460

Ishida Y, Kuninaka Y, Mukaida N, et al. 2023 Immune mechanisms of pulmonary fibrosis with bleomycin. Int. J. Mol. Sci. 5 3149

Article  Google Scholar 

Iside C, Scafuro M, Nebbioso A, et al. 2020 SIRT1 activation by natural phytochemicals: An overview. Front. Pharmacol. 11 1225

Kong F, Ma L, Wang X, et al. 2022 Regulation of epithelial-mesenchymal transition by protein lysine acetylation. Cell Commun. Signal. 20 57

Lee CW, Wong LL, Tse EY, et al. 2013 AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res. 72 4394–4404

Article  Google Scholar 

Li M, Zheng Y, Yuan H, et al. 2017 Effects of dynamic changes in histone acetylation and deacetylase activity on pulmonary fibrosis. Int. Immunopharmacol. 52 272–280

Article  CAS  PubMed  Google Scholar 

Li X, Zhang H, Soledad-Conrad V, et al. 2003 Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo. Am. J. Physiol. Lung Cell. Mol. Physiol. 284 501–507

Article  Google Scholar 

Liu L, Sun Q, Davis F, et al. 2022 Epithelial-mesenchymal transition in organ fibrosis development: Current understanding and treatment strategies. Burn Trauma 10 tkac011

Maiese K 2020 Nicotinamide: Oversight of metabolic dysfunction through SIRT1, mTOR, and Clock genes. Curr. Neurovasc. Res. 17 765–783

CAS  PubMed  PubMed Central  Google Scholar 

Mansour HH, Omran MM, Hasan HF, et al. 2020 Modulation of bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in rats via AMPK/SIRT1/NF-κβ. Clin. Exp. Pharmacol. Physiol. 12 1943–1952

Article  Google Scholar 

Mazumder S, Barman M, Bandyopadhyay U, et al. 2020 Sirtuins as endogenous regulators of lung fibrosis: A current perspective. Life Sci. 258 118201

Article  CAS  PubMed  Google Scholar 

Meza-Ríos A, García-Benavides L, García-Bañuelos J, et al. 2016 Simultaneous administration of ADSCs-based therapy and gene therapy using Ad-huPA reduces experimental liver fibrosis. PLoS One 11 e0166849

Palliyaguru DL, Minor RK, Mitchell SJ, et al. 2020 Combining a high dose of metformin with the SIRT1 activator, SRT1720, Reduces life span in aged mice fed a high-fat diet. J. Gerontol. A Biol. Sci. Med. Sci. 75 2037–2041

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park JA, Kim AJ, Kang Y, et al. 2011 Deacetylation and methylation at histone H3 lysine 9 (H3K9) coordinate chromosome condensation during cell cycle progression. Mol. Cells 31 343–349

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park SJ, Ahmad F, Um JH, et al. 2017 Specific Sirt1 activator-mediated improvement in glucose homeostasis requires sirt1-independent activation of AMPK. EBioMedicine 18 128–138

Article  PubMed  PubMed Central  Google Scholar 

Ramis MR, Esteban S, Miralles A, et al. 2015 Caloric restriction, resveratrol and melatonin: Role of SIRT1 and implications for aging and related-diseases. Mech. Ageing Dev. 148 28–41

Article  Google Scholar 

Rana T, Jiang C, Banerjee S, et al. 2023 PAI-1 regulation of p53 expression and senescence in type II alveolar epithelial cells. Cells 12 2008

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruigrok MJR, Frijlink HW, Melgert BN, et al. 2021 Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions. Mol. Ther. Methods Clin. Dev. 20 483–496

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sandoval-Rodriguez A, Monroy-Ramirez HC, Meza-Rios A, et al. 2020 Pirfenidone is an agonistic ligand for PPARα and improves NASH by activation of SIRT1/LKB1/pAMPK. Hepatol. Commun. 4 434–449

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scisciola L, Sarno F, Carafa V, et al. 2020 Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence. Epigenetics 15 664–683

Article  PubMed  PubMed Central  Google Scholar 

Shetty SK, Tiwari N, Marudamuthu AS, et al. 2017 p53 and mir-34a feedback promotes lung epithelial injury and pulmonary fibrosis. Am. J. Pathol. 187 1016–1034

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siller-López F, García-Bañuelos J, Hasty KA, et al. 2000 Truncated active matrix metalloproteinase-8 gene expression in Hepg2 cells is active against native type I collagen. J. Hepatol. 33 758–763

Article  PubMed  Google Scholar 

Singh V and Ubaid S 2020 Role of Silent Information Regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation 43 1589–1598

Article  CAS  PubMed  Google Scholar 

Solomon JM, Pasupuleti R, Xu L, et al. 2006 Inhibition of sirt1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol. Cell. Biol. 26 28–38

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song YM, Lee YH, Kim JW, et al. 2015 Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. Autophagy 11 46–59

Article